Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Advisory Board Appointment

18 Aug 2021 07:00

RNS Number : 9416I
DeepMatter Group PLC
18 August 2021
 

18 August 2021

 

DeepMatter Group Plc

DeepMatter CEO appointed Chairman of Industrial Advisory Board at Imperial College

DeepMatter Group Plc (AIM: DMTR, "DeepMatter", the "Group"), which focuses on digitalising chemistry, announces that its CEO, Mark Warne, has been invited to chair the Industrial Advisory Board (IAB) at Imperial College's EPSRC Centre for Doctoral Training in Next Generation Synthesis & Reaction Technology (CDT), for the next two years.

Mark's principal role will be to liaise closely with the CDT's network of industrial partners, including AstraZeneca, Bayer, BASF, GlaxoSmithKline, IBM, The Janssen Pharmaceutical Companies of Johnson & Johnson, Mettler-Toledo, Syngenta, and Pfizer. 

These partners provide industrial advice and feedback on the CDT's research direction as well as making recommendations in the areas of chemistry, chemical engineering and data science.

Mark Warne, DeepMatter CEO, commented:

"This appointment will enable me to work closely with a number of multinational pharma companies and Key Opinion Leaders - all of whom are committed to integrating chemistry with technology and sharing their expertise and experience with the chemists of the future.

"This appointment is a further validation of DeepMatter's position at the centre of the digitalisation of chemistry and the development of big data and analytics for the chemists in early-stage formulation."

The CDT is made up of a multi-disciplinary team of internationally-leading researchers at Imperial College. It benefits from significant infrastructural and capital investment on its state-of-the-art technology and facilities such as The Centre for Rapid Online Analysis of Reactions (ROAR).

The CDT aims to engage with the Centres of Excellence in the US and Europe, to deliver a unique multi-faceted training programme in order to improve the skills, employability and productivity of the graduates and to equip them for future academic and industrial roles.

Jinata Subba, EPSRC CDT Programme Manager, Dept of Chemistry, Imperial College, added:

 "DeepMatter's knowledge and experience of automation in chemistry will help us on our mission to transform synthetic chemistry into a truly data-driven discipline. Automation enables researchers to gather and share huge amounts of data about chemical reactions, which can then be used to optimize processes and even forecast the outcomes of entirely new reactions.

"There is a skills gap between academic training and the experimental methods used routinely in industry. At Imperial College our programme aims to equip students for the future of synthetic chemistry. The advice and feedback from the Industrial Advisory Board is proving invaluable.

"DeepMatter's mission of digitising chemistry using cutting edge analytical instruments and Machine Learning techniques resonates with the way we are pioneering this approach to training."

 

For more information, please contact:

 

DeepMatter Group PlcMark Warne, Chief Executive Officer 0141 548 8156

Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000Bobbie Hilliam

Meare Consulting 07990 858548Adrian Duffield

 

About DeepMatter Group Plc 

DeepMatter is building and commercialising the most powerful data platforms, to enable scientists to easily perform and optimise chemical reactions, by increasingly integrating chemistry with technology. Ultimately this will allow the greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics.

Visit: www.deepmatter.io and follow @deepmattergroup

 

About the EPSRC Centre for Doctoral Training in Next Generation Synthesis & Reaction Technology

The mission of the Next Generation Synthesis & Reaction Technology CDT is to educate a critical mass of researchers equipped to respond to future research challenges and opportunities created by the data-revolution. The aim is to train highly qualified researchers with the ability to collect data using automated, high-throughput reaction platforms, and to apply quantitative and statistical approaches to data analysis and utilisation. This will be achieved by incorporating cross-disciplinary skills from engineering, as well as computing, statistics, and informatics into a chemistry graduate programme, which are largely lacking from existing doctoral training in synthetic chemistry.

Visit: www.imperial.ac.uk/next-generation-synthesis-reaction-technology/the-cdt-programme/

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABUGDIBGBDGBR
Date   Source Headline
14th Jun 20127:00 amRNSBusiness Development Agreement
29th May 20124:03 pmRNSAGM Statement
25th Apr 20127:00 amRNSPreliminary Results - Commercialisation Underway
24th Feb 20127:00 amRNSAnti-Reflective Technology Development
26th Jan 20122:55 pmRNSHolding(s) in Company
3rd Jan 201212:16 pmRNSHolding(s) in Company
17th Oct 20117:00 amRNSAppointment of Chairman
30th Sep 20117:00 amRNSInterim Results
9th Aug 201110:30 amRNSIndustry leading Anti-Reflective Coating
16th Jun 20119:53 amRNSAnnual Financial Report
21st Apr 20117:00 amRNSJapan Agent Appointed
30th Mar 20117:05 amRNSDirectorate Change
30th Mar 20117:00 amRNSAnnual Financial Report
25th Feb 20117:00 amRNSDirectorate Change
27th Jan 201112:44 pmRNSHolding(s) in Company
24th Jan 20111:18 pmRNSHolding(s) in Company
2nd Dec 20107:00 amRNSTrading Update
30th Nov 20107:00 amRNSOAS delivers key process
29th Sep 20107:00 amRNSInterim results
27th Sep 20101:52 pmRNSHolding(s) in Company
14th Jul 201011:23 amRNSHolding(s) in Company
24th Jun 201011:19 amRNSHolding(s) in Company
16th Jun 20104:31 pmRNSHolding(s) in Company
4th Jun 20103:36 pmRNSHolding(s) in Company
2nd Jun 201010:06 amRNSHolding(s) in Company
28th May 20103:14 pmRNSHolding(s) in Company
25th May 20102:26 pmRNSResult of AGM
7th May 201012:49 pmRNSChange of Adviser
28th Apr 20107:00 amRNSFinal Results
16th Feb 20102:55 pmRNSHolding(s) in Company
12th Feb 201012:59 pmRNSHolding(s) in Company
12th Feb 20107:00 amRNSNotification of Interest
9th Feb 20108:58 amRNSDirectorate Change
4th Jan 20107:00 amRNSDirectorate Change
2nd Dec 200910:13 amRNSAward of Options
25th Sep 20097:00 amRNSDirectorate Change and Interim Results
29th May 20093:37 pmRNSAward of Share Options
22nd May 20099:45 amRNSAGM Statement
27th Apr 20097:00 amRNSPreliminary Results
16th Apr 20094:32 pmRNSNotice of AGM
7th Jan 200911:30 amRNSResignation of Director
18th Dec 200810:59 amRNSAward of Share Options
19th Nov 20087:00 amRNSDirectorate Change
11th Nov 20082:48 pmRNSChange of Auditor
30th Oct 20087:00 amRNSHolding(s) in Company
16th Oct 20087:00 amRNSBusiness Update & new Development Agreement signed
15th Oct 20084:34 pmRNSHolding(s) in Company
29th Sep 20087:00 amRNSInterim Results
9th Sep 20081:51 pmRNSHolding(s) in Company
1st Aug 20087:00 amRNSFundraising and Appointment o

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.